Mitchell Jones, M.D., Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Palisade Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get PALI alerts

About Mitchell Jones, M.D., Ph.D.

Palisade Bio, Inc. reported in an 8-K filed September 11, 2023 that Mitchell Jones, M.D., Ph.D. was appointed Chief Medical Officer, effective September 5, 2023. Mitchell Jones, M.D., Ph.D. has spoken on 1 investor event across 1 company, most recently for Palisade Bio, Inc. on June 4, 2026. Palisade Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palisade Bio, Inc. includes J.D. Finley (CEO, CFO and Board Member), Dane R. Saglio (CFO), Matthew W. Kalnik, Ph.D. (COO) and 7 others.

“On September 11, 2023, Palisade Bio, Inc. (the “Company”) announced that Mitchell Jones, M.D., Ph.D. (“Dr. Jones”) has been appointed Chief Medical Officer effective September 5, 2023 (the “Effective Date”).”

Palisade Bio, Inc. Form 8-K, filed September 11, 2023 · Read the filing

Mitchell Jones, M.D., Ph.D. on recent calls

“So I'll try to move through these slides so there's time at the end for questions and answers. This is really just our corporate deck, so try and hit the key points.”

Other, Jefferies Global Healthcare Conference · June 4, 2026